ETRACS 2x Leveraged US Dividend Factor TR ETN

SCDL offers 2x exposure to the Dow Jones US Dividend 100 Indexa market-cap-weighted index that excludes REITs and screens for firms with a 10-year history of paying dividends. The index portfolio is curated using the following fundamental metrics: cash-flow to debt ratio, ROE, dividend yield and dividend growth rate. This approach gives a modest large-cap tilt, and comes with sector biases that lean toward industrials and consumer stocks, and away from financials. Unlike other ETNs, SCDL does not pay any coupon. It also resets its leverage quarterly, rather than daily. And like all ETNs, SCDL is not directly backed by stocks but by the credit of the issuing bank, UBS. The underlying index is reviewed annually and rebalanced quarterly.

ETRACS 2x Leveraged US Dividend Factor TR ETN trades as SCDL on AMEX. The company is classified in Financial Services / Asset Management - Leveraged and reports in USD.

The current profile places the business in Asset Management - Leveraged. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

ETRACS 2x Leveraged US Dividend Factor TR ETN can be compared against peers such as ETRACS Quarterly Pay 1.5x Leveraged MarketVector BDC Liquid Index ETN, MicroSectors Solactive FANG & Innovation -3X Inverse Leveraged ETN, ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN, Invesco S&P 500 High Dividend Growers ETF, Invesco High Yield Select ETF, ETRACS 2x Leveraged US Size Factor TR ETN.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $10.60M, beta of 1.17, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

SCDL currently shows total debt of N/A and beta of 1.17. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

Recent filings to review: 424B2 (2026-06-05 00:00:00), 424B2 (2026-06-05 00:00:00), 424B2 (2026-06-05 00:00:00), 424B2 (2026-06-05 00:00:00).

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://etracs.ubs.com/product/detail/index/ussymbol/SCDL

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.